BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38485277)

  • 1. Strong Correlation Between SUV
    Berrens AC; Sorbi MA; Donswijk ML; de Barros HA; Azargoshasb S; van Oosterom MN; Rietbergen DDD; Bekers EM; van der Poel HG; van Leeuwen FWB; van Leeuwen PJ
    J Nucl Med; 2024 Apr; 65(4):548-554. PubMed ID: 38485277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robot-assisted Prostate-specific Membrane Antigen-radioguided Salvage Surgery in Recurrent Prostate Cancer Using a DROP-IN Gamma Probe: The First Prospective Feasibility Study.
    de Barros HA; van Oosterom MN; Donswijk ML; Hendrikx JJMA; Vis AN; Maurer T; van Leeuwen FWB; van der Poel HG; van Leeuwen PJ
    Eur Urol; 2022 Jul; 82(1):97-105. PubMed ID: 35339318
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Maurer T; Robu S; Schottelius M; Schwamborn K; Rauscher I; van den Berg NS; van Leeuwen FWB; Haller B; Horn T; Heck MM; Gschwend JE; Schwaiger M; Wester HJ; Eiber M
    Eur Urol; 2019 Apr; 75(4):659-666. PubMed ID: 29625755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of
    Koehler D; Sauer M; Klutmann S; Apostolova I; Lehnert W; Budäus L; Knipper S; Maurer T
    J Nucl Med; 2023 Jan; 64(1):59-62. PubMed ID: 35835582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate-Specific Membrane Antigen-Targeted Radioguided Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients with a Suspicion of Locoregional Lymph Node Metastases: The DETECT Trial.
    Schilham MGM; Somford DM; Küsters-Vandevelde HVN; Hermsen R; van Basten JPA; Hoekstra RJ; Scheenen TWJ; Gotthardt M; Sedelaar JPM; Rijpkema M
    J Nucl Med; 2024 Mar; 65(3):423-429. PubMed ID: 38176721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific membrane antigen radioguided surgery with negative histopathology: an in-depth analysis.
    Koehler D; Trappe S; Shenas F; Karimzadeh A; Apostolova I; Klutmann S; Ambrosini F; Budäus L; Falkenbach F; Knipper S; Maurer T
    Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):548-557. PubMed ID: 37750908
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Yılmaz B; Şahin S; Ergül N; Çolakoğlu Y; Baytekin HF; Sökmen D; Tuğcu V; Taşçı Aİ; Çermik TF
    Ann Nucl Med; 2022 Jul; 36(7):597-609. PubMed ID: 35426599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robot-Assisted Prostate-Specific Membrane Antigen-Radioguided Surgery in Primary Diagnosed Prostate Cancer.
    Gondoputro W; Scheltema MJ; Blazevski A; Doan P; Thompson JE; Amin A; Geboers B; Agrawal S; Siriwardana A; Van Leeuwen PJ; van Oosterom MN; Van Leeuwen FWB; Emmett L; Stricker PD
    J Nucl Med; 2022 Nov; 63(11):1659-1664. PubMed ID: 35241483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of patients with biochemical recurrence of prostate cancer after PSMA PET/CT-directed radiotherapy or surgery without systemic therapy.
    Harsini S; Wilson D; Saprunoff H; Allan H; Gleave M; Goldenberg L; Chi KN; Kim-Sing C; Tyldesley S; Bénard F
    Cancer Imaging; 2023 Mar; 23(1):27. PubMed ID: 36932416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic performance of 68GA-PSMA PET/CTin patients with prostate cancer].
    Veliev EI; Tomilov AA; Goncharuk DA; Bogdanov AB; Golubtsova EN
    Urologiia; 2018 Jul; (3):105-110. PubMed ID: 30035428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study.
    Gandaglia G; Mazzone E; Stabile A; Pellegrino A; Cucchiara V; Barletta F; Scuderi S; Robesti D; Leni R; Samanes Gajate AM; Picchio M; Gianolli L; Brembilla G; De Cobelli F; van Oosterom MN; van Leeuwen FWB; Montorsi F; Briganti A
    Eur Urol; 2022 Oct; 82(4):411-418. PubMed ID: 35879127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via Prostate-specific Membrane Antigen-radioguided Surgery.
    Knipper S; Mehdi Irai M; Simon R; Koehler D; Rauscher I; Eiber M; van Leeuwen FWB; van Leeuwen P; de Barros H; van der Poel H; Budäus L; Steuber T; Graefen M; Tennstedt P; Heck MM; Horn T; Maurer T
    Eur Urol; 2023 Jan; 83(1):62-69. PubMed ID: 35718637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed Imaging Improves Lesion Detectability in [
    Berliner C; Steinhelfer L; Chantadisai M; Kroenke M; Koehler D; Pose R; Bannas P; Knipper S; Eiber M; Maurer T
    J Nucl Med; 2023 Jul; 64(7):1036-1042. PubMed ID: 37230531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [
    Rosar F; Burgard C; Larsen E; Khreish F; Marlowe RJ; Schaefer-Schuler A; Maus S; Petto S; Bartholomä M; Ezziddin S
    Cancer Imaging; 2024 Feb; 24(1):27. PubMed ID: 38389092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysis.
    Spohn SKB; Farolfi A; Schandeler S; Vogel MME; Ruf J; Mix M; Kirste S; Ceci F; Fanti S; Lanzafame H; Serani F; Gratzke C; Sigle A; Combs SE; Bernhardt D; Gschwend JE; Buchner JA; Trapp C; Belka C; Bartenstein P; Unterrainer L; Unterrainer M; Eiber M; Nekolla SG; Schiller K; Grosu AL; Schmidt-Hegemann NS; Zamboglou C; Peeken JC
    Eur J Nucl Med Mol Imaging; 2022 Dec; 50(1):218-227. PubMed ID: 35984452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incremental Impact of [
    Szigeti F; Schweighofer-Zwink G; Meissnitzer M; Hauser-Kronberger C; Hitzl W; Kunit T; Forstner R; Pirich C; Beheshti M
    Mol Imaging Biol; 2022 Feb; 24(1):50-59. PubMed ID: 34519966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of
    Albisinni S; Artigas C; Aoun F; Biaou I; Grosman J; Gil T; Hawaux E; Limani K; Otte FX; Peltier A; Sideris S; Sirtaine N; Flamen P; van Velthoven R
    BJU Int; 2017 Aug; 120(2):197-203. PubMed ID: 27981732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic sensitivity of Tc-99m HYNIC PSMA SPECT/CT in prostate carcinoma: A comparative analysis with Ga-68 PSMA PET/CT.
    Lawal IO; Ankrah AO; Mokgoro NP; Vorster M; Maes A; Sathekge MM
    Prostate; 2017 Aug; 77(11):1205-1212. PubMed ID: 28649735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of
    Rauscher I; Düwel C; Wirtz M; Schottelius M; Wester HJ; Schwamborn K; Haller B; Schwaiger M; Gschwend JE; Eiber M; Maurer T
    BJU Int; 2017 Jul; 120(1):40-47. PubMed ID: 27862863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.